Company Description
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People’s Republic of China.
The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine.
It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs.
In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors.
The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
| Country | China |
| Founded | 2004 |
| IPO Date | Jan 7, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 269 |
| CEO | Songlin Song |
Contact Details
Address: No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin China | |
| Phone | 86 432 6304 7008 |
| Website | jlzybio.com |
Stock Details
| Ticker Symbol | ZYBT |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| IPO Price | $4.00 |
| CIK Code | 1975641 |
| CUSIP Number | G989MS101 |
| ISIN Number | KYG989MS1016 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Aiden Han | Co-Chief Executive Officer |
| Songlin Song | Co-Chief Executive Officer |
| Ping Wang | Chief Financial Officer |
| Zhongyao Liu | Chief Operating Officer |
| Yuhong Cheng | Vice General Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 4, 2026 | 6-K | Report of foreign issuer |
| Apr 28, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Mar 25, 2026 | 6-K | Report of foreign issuer |
| Mar 2, 2026 | 6-K | Report of foreign issuer |
| Feb 23, 2026 | 6-K | Report of foreign issuer |
| Dec 12, 2025 | 6-K | Report of foreign issuer |
| Oct 22, 2025 | 144 | Filing |
| Oct 22, 2025 | 144 | Filing |
| Jul 3, 2025 | 20-F | Annual and transition report of foreign private issuers |
| May 23, 2025 | 6-K | Report of foreign issuer |